| Accession Number | 0002019992-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 1, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sr. VP of Clinical Development | Common Stock | โ | Mar 27, 2026 | Sale | 4,256 | $30.04 | $127,837.47 | 42,149 | Direct | โ | View Details | |
Sr. VP of Clinical Development | Common Stock | โ | Mar 27, 2026 | Sale | 1,838 | $31.04 | $57,048.58 | 40,311 | Direct | โ | View Details | |
Sr. VP of Clinical Development | Common Stock | โ | Mar 27, 2026 | Sale | 488 | $31.72 | $15,478.73 | 39,823 | Direct | โ | View Details |